Sclerostin (murine) protein. Causes decreased bone formation by inhibiting the Wnt signaling pathway. Target of romosozumab, a monoclonal antibody.

---

Sclerostin (murine) protein. Causes decreased bone formation by inhibiting the Wnt signaling pathway. Target of romosozumab, a monoclonal antibody for the treatment of osteoporosis. 3D rendering based on protein data bank entry 2kd3. Atoms are represented as spheres with conventional color coding.

---

Size: 4096px × 4096px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: 3d, acid, amino, atoms, bone, buchem, calcitonin, disease, gene, growth, health, illustration, model, molecular, molecule, osteocyte, osteoporosis, pathway, pdb_2kd3, peptide, polymer, polypeptide, protein, regulator, rendering, romosozumab, science, scientific, sclerosteosis, sclerostin, signaling, sost, structure, van, wnt